Provided by Tiger Trade Technology Pte. Ltd.

Arbutus Biopharma

5.21
+0.44009.22%
Post-market: 5.290.0781+1.50%19:59 EDT
Volume:18.07M
Turnover:94.18M
Market Cap:1.03B
PE:6.60
High:5.45
Open:5.20
Low:5.09
Close:4.77
52wk High:5.45
52wk Low:3.49
Shares:196.94M
Float Shares:123.00M
Volume Ratio:10.07
T/O Rate:14.69%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.7896
EPS(LYR):-0.1748
ROE:89.58%
ROA:48.84%
PB:3.97
PE(LYR):-29.80

Loading ...

Top News Today/Canada: Pet Valu Trims Outlook Amid Squeezed Margins

Dow Jones
·
May 13

BUZZ-U.S. STOCKS ON THE MOVE-Nike, PNC Financia, OSI Systems

Reuters
·
Apr 16

Arbutus says FDA grants Fast Track designation for imdusiran in chronic hepatitis B

Reuters
·
Apr 15

Arbutus Receives U.S. FDA Fast Track Designation for Imdusiran for the Treatment of Chronic Hepatitis B

THOMSON REUTERS
·
Apr 15

Arbutus Biopharma announces annual general and special shareholders meeting

Reuters
·
Apr 15

Arbutus Biopharma price target lowered to $5.50 from $7 at Jefferies

TIPRANKS
·
Apr 07

Arbutus Biopharma Corp reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 25

Arbutus Biopharma Q4 EPS $(0.01) Beats $(0.03) Estimate, Sales $1.051M Miss $1.233M Estimate

Benzinga Earnings
·
Mar 23

Earnings Flash (ABUS) Arbutus Biopharma Posts 2025 Loss $0.17 a Share, vs. FactSet Est of $0.19 Loss

MT Newswires Live
·
Mar 23

Arbutus Biopharma advances imdusiran and AB-101 for chronic hepatitis B treatment

Reuters
·
Mar 23

Arbutus Biopharma FY 2025 net loss was USD 34 million, revenue rose 128% to USD 14 million

Reuters
·
Mar 23

Press Release: Arbutus Reports Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update

Dow Jones
·
Mar 23

Sector Update: Health Care Stocks Advance Late Afternoon

MT Newswires Live
·
Mar 05

Moderna litigation outcome ‘favorable,’ but leaves some risk, says BofA

TIPRANKS
·
Mar 04

BUZZ-Street View: Wall Street views Moderna's legal settlement as clearing a major overhang

Reuters
·
Mar 04

Moderna Stock Rallies. This Big Risk Just Got Eliminated. -- Barrons.com

Dow Jones
·
Mar 04

24H | Moderna and TotalEnergies Jump 8%; GitLab Drops 8%; Arbutus Biopharma Sinks 12%

Tiger Newspress
·
Mar 04

Stocks to Watch: Moderna, Ross Stores, Latham, Webtoon

Dow Jones
·
Mar 04

Moderna Agrees to Pay up to $2.25 Billion to Settle COVID Vaccine Patent Dispute

Reuters
·
Mar 04

BRIEF-Genevant Sciences And Arbutus Biopharma Announce $2.25 Billion Global Settlement With Moderna

Reuters
·
Mar 04